MELAX
Price
$15.34
Change
-$0.13 (-0.84%)
Updated
Nov 14 closing price
VEMRX
Price
$95.47
Change
-$0.52 (-0.54%)
Updated
Nov 14 closing price
Ad is loading...

MELAX vs VEMRX

Header iconMELAX vs VEMRX Comparison
Open Charts MELAX vs VEMRXBanner chart's image
Morgan Stanley Inst EMkts Ldrs A
Price$15.34
Change-$0.13 (-0.84%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx InsPlus
Price$95.47
Change-$0.52 (-0.54%)
VolumeN/A
CapitalizationN/A
MELAX vs VEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MELAX vs. VEMRX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MELAX is a Buy and VEMRX is a Sell.

FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 113B vs. MELAX (230M). VEMRX pays higher dividends than MELAX: VEMRX (3.48) vs MELAX (0.00). MELAX was incepted earlier than VEMRX: MELAX (10 years) vs VEMRX (14 years). MELAX is a more actively managed with annual turnover of: 54.00 vs. VEMRX (5.00). MELAX has a lower initial minimum investment than VEMRX: MELAX (1000) vs VEMRX (100000000). VEMRX annual gain was more profitable for investors over the last year : 16.45 vs. MELAX (14.85). MELAX return over 5 years is better than : 25.77 vs. VEMRX (18.29).
MELAXVEMRXMELAX / VEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years14 years-
Gain YTD7.73011.66966%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets230M113B0%
Annual Yield % from dividends0.003.48-
Returns for 1 year14.8516.4590%
Returns for 3 years-27.91-6.28445%
Returns for 5 years25.7718.29141%
Returns for 10 yearsN/A28.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFAM111.14-0.44
-0.39%
Bright Horizons Family Solutions
SENEA65.49-0.48
-0.73%
Seneca Foods Corp
UBS31.62-0.44
-1.37%
UBS Group AG
DTIL8.08-0.29
-3.46%
Precision BioSciences
SYRE32.97-2.84
-7.94%
Spyre Therapeutics